Pinealon 10mg 10vials

Description

Pinealon Neural Peptide Bioregulator for Brain Function Research

Product Specifications

• CAS Number: 147391-03-3
• Molecular Formula: C15H26N6O8
• Molecular Weight: 418.4 Da
• Purity: >99.0% via HPLC-UV and Mass Spectrometry
• Appearance: Fine white sterile lyophilizate

Pharmacodynamics

The biochemical activity of Pinealon is defined by its high degree of cell permeability and subsequent nuclear localization. The primary mechanism involves the tripeptide penetrates the neuronal cell membrane and translocates into the nucleus. This defines the first semantic triple: [Pinealon penetrates the cell nucleus]. Additionally, it binds directly to the double-stranded DNA structure, specifically targeting the promoter regions of genes involved in neurogenesis and telomerase activity. This establishes the second triple: [Glu-Asp-Arg binds to chromatin structures]. Furthermore, this interaction facilitates the unwrapping of condensed chromatin, leading to the up-regulation of mRNA transcription for vital structural proteins. This forms the third triple: [Pinealon modulates gene expression in cortical neurons]. Quantitatively, Pinealon demonstrates a systemic half-life of approximately 35 minutes, yet its downstream epigenetic signaling can maintain biological alterations for 3 to 6 months post-administration. Unlike Cortagen (Ala-Glu-Asp-Gly), which exhibits a more pronounced focus on prefrontal cortex repair, Pinealon demonstrates higher selectivity for the pineal gland and the suprachiasmatic nucleus.

Compound Background

Pinealon is a synthetic short-chain peptide bioregulator composed of the amino acids Glutamyl-Aspartyl-Arginine (Glu-Asp-Arg). As a member of the cytogen family, it is specifically engineered to interact with the epigenetic landscape of the central nervous system. [Pinealon targets cortical neurons]. It serves as a primary research tool for investigating the restoration of neuronal protein synthesis and the optimization of circadian rhythms.

Experimental Outcomes

• Enhanced Cognitive Processing: Users report significant improvements in short-term memory retention and mental processing speed during periods of cognitive fatigue.
• Circadian Rhythm Stabilization: Published research indicates accelerated adaptation to phase-shift stressors, such as jet lag or rotating shift work.
• Neuroprotective Resilience: According to research documentation, research models show a reduction in oxidative markers and apoptotic signaling in neurons subjected to hypoxic stress.
• Improved Sleep Architecture: Cumulative findings indicate deeper restorative sleep phases without the grogginess associated with traditional sedatives.
• Mood Regulation Support: Research models have observed a stabilizing effect on neurotransmitter levels, particularly during models of chronic psychological stress.

Key Points:
Pinealon represents a high-feasibility research tool for investigating the targeted epigenetic modulation of neural tissue and the molecular mechanisms of circadian regulation.

Frequently Asked Questions

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Consult a qualified healthcare professional before use.